Inhibition of polyamine oxidase enhances the cytotoxicity of polyamine oxidase substrates. A model study with N1-(n-octanesulfonyl)spermine and human colon cancer cells

International Journal of Biochemistry and Cell Biology

Volumn 32, Issue 7, 2000, Pages 703-716

  Seiler, N ^c   Duranton, B ^c   Vincent, F ^a   Gosse F ^c   Renault, J ^b   Raul, F ^c  

^a IRCAD   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c NONE

Author keywords

CaCo 2 cells; Cytotoxicity; Polyamine oxidase; Polyamines

Indexed keywords

HYDROGEN PEROXIDE; POLYAMINE OXIDASE; SPERMINE;

ANIMAL CELL; ARTICLE; CANCER CELL; CATALYSIS; CELL DIFFERENTIATION; CHEMICAL REACTION; COLON CANCER; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; TUMOR CELL CULTURE;

APOPTOSIS; CACO-2 CELLS; CASPASES; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOTOXINS; DNA FRAGMENTATION; HUMANS; ORNITHINE DECARBOXYLASE; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; SPERMINE; SULFONAMIDES;

ANIMALIA;

EID: 0034237206     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(00)00022-4     Document Type: Article

References (38)

1. Bolkenius F.N., Seiler N. Acetyl derivatives as intermediates in polyamine catabolism. Int. J. Biochem. 13:1981;287-292.
2. 1(n-octanesulfonyl)-spermine, novel glutamate receptor antagonists: block and permeation of N-methyl-D-asparate receptors. Mol. Pharmacol. 51:1997;861-871.
3. Seiler N., Douaud F., Renault J., Delcros J.G., Havouis R., Uriac P., Moulinoux J.P. Polyamine sulfonamides with NMDA antagonist properties are potent calmodulin antagonists and cytotoxic agents. Int. J. Biochem. Cell Biol. 30:1998;393-406.
4. Seiler N., Bolkenius F.N., Bey P., Mamont P.S., Danzin C. Biochemical significance of polyamine oxidase. Selmeci L., Brosnanrecent M.E., Seiler N. Recent Progress in Polyamine Research. 1985;305-319 Adakemiai Kiado, Budapest.
5. Moya E., Blagbrough I.S. Syntheses and neuropharmacological properties of arthropod polyamine amide toxins. Carter C. The Neuropharmacology of Polyamines. 1994;168-184 Academic Press, London.
6. Brunton V.G., Grant M.H., Wallace H.M. Mechanism of spermine toxicity in baby hamster kidney (BHK) cells. Biochem. J. 280:1991;193-198.
7. N. Seiler, B. Duranton, F. Gossé, F. Raul, Spermine cytotoxicity to human colon carcinoma-derived cells (CaCo-2), Cell Biol. (in press).
8. Linsalata M., Cavallini A., DiLeo A. Polyamine oxidase activity and polyamine levels in human colorectal cancer and in normal surrounding mucosa. Anticancer Res. 17:1997;3757-3760.
9. Bey P., Bolkenius F.N., Seiler N., Casara P. N-2, 2-Butadienyl-1,4-butanediamine derivatives: Potent irreversible inactivators of mammalian polyamine oxidase. J. Med. Chem. 28:1985;1-2.
10. Bolkenius F.N., Seiler N. Polyamine oxidase inhibitors. Sandler M., Smith H.J. Design of Enzyme Inhibitors as Drugs. 1989;245-256 Oxford University Press, Oxford.
11. Fogh J., Fogh J.M., Orfeo T. One hundred and twenty seven cultured human tumor cell lines producing tumors in nude mice. J. Natl. Cancer Inst. 59:1977;221-226.
12. Pinto M., Robin-Leon S., Appay M.D., Kedinger M., Triadou N., Dussaulx B., Lacroix P., Simon-Assmann K., Haffen K., Fogh J., Zweibaum A. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line CaCo-2 in culture. Biol. Cell. 47:1983;323-330.
13. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistca D., Warran J.T., Bokesch H., Kennedy S., Boyd M.R. New colorimetric cytotoxicity assay for anti-cancer drug screening. J. Natl. Cancer Inst. 82:1990;1107-1112.
14. Crissman H.A., Mullner P.F., Steinkamp J.A. Methods and application of flow systems for analysis and sorting of mammalian cells. Meth. Cell Biol. 9:1975;195-221.
15. Seiler N., Sarhan S., Grauffel C., Jones R., Knödgen B., Moulinoux J.P. Endogenous and exogenous polyamines in support of tumor growth. Cancer Res. 50:1990;5077-5083.
16. Hayashi S.I., Kameji T. Ornithine decarboxylase (Rat liver). Tabor H., Tabor C.W. Methods in Enzymology. 1983;154-158 Academic Press, New York.
17. H. Hayashi, H. Yoshida, F. Hashimoto, S. Okazeri, Changes in polyamine-oxidizing capacity of peroxisomes under various physiological conditions in rats, Biochim. Biophys. Acta 991 (1989) 310-316.
18. Schmitz J., Preiser H., Maestracci D. Purification of human intestinal brush border membrane. Biochim. Biophys. Acta. 323:1973;98-112.
19. Messer M., Dahlqvist A. A one-step ultramicromethod for the assay of intestinal disaccharidases. Anal. Biochem. 193:1966;265-275.
20. Garen A., Levinthal C. A fine structure genetic and chemical study of the enzyme alkaline phosphatase of E. coli. 1. Purification and characterization of alkaline phosphatase. Biochim. Biophys. Acta. 38:1960;470-483.
21. Nicholson D.W., Ali A., Thornberry N.A., Villaincourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle L., Laezbnik Y.A. Identification and inhibition of ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-44.
22. Lowry O.G., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
23. D'Agostino L., Daniele B., Pignata S., Gentile S., Tagaliaferri P., Contegiacomo A., Silvestro G., Polistina C., Bianco A.R., Mazzaca G. Ornithine decarboxylase and diamine oxidase in human colon carcinoma cell line CaCo-2 in culture. Gastroenterology. 97:1989;888-894.
24. Johnson J.D., Mills J.S. Calmodulin Med. Res. Rev. 6:1986;341-363.
25. Klee C.B., Crouch T.H., Richman P.G. Calmodulin Ann. Rev. Biochem. 49:1980;489-515.
26. Rasmussen C.D., Means A. Calmodulin, cell growth and gene expression. TINS. 12:1989;433-438.
27. Hait W.N. Targeting calmodulin for the development of novel cancer chemotherapeutic agents. Anti-Cancer Drug Design. 2:1987;139-149.
28. 1-acetyltransferase. The turning point in polyamine metabolism. FASEB J. 7:1993;653-661.
29. Seiler N. Functions of polyamine acetylation. Can. J. Physiol. Pharmacol. 65:1987;2024-2035.
30. Flayeh K.A., Wallace H. Polyamine oxidase activity in a human colonic carcinoma cell line. Biochem. Soc. Trans. 18:1990;1225.
31. D'Agostino L., Pignata S., Daniele B., D'Adamo G., Ferraro C., Silvestro G., Tagliaferri P., Contegiacomo A., Gentile R., Tritto G., Bianco A.R., Mazzacca G. Polyamine uptake by human colon carcinoma cell line CaCo-2. Digestion. 46:(Suppl. 2):1990;352-359.
32. Dai H., Kramer D.L., Yanag C., Murti K.G., Porter C.W., Cleveland J.L. The polyamine oxidase inhibitor MDL 72527 selectively induces apoptosis of transformed haematopoietic cells through lysosomotropic effect. Cancer Res. 59:1999;4944-4954.
33. Duranton B., Keith G., Gossé F., Bergmann C., Schleiffer R., Raul F. Concomitant changes in polyamine pools and DNA methylation during growth inhibition of human colon carcinoma cells. Exp. Cell Res. 243:1998;319-325.
34. Haunstetter A., Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ. Res. 82:1998;1111-1129.
35. Thornberry N.A., Rosen A., Nicholson D.A. Control of apoptosis by proteases. Adv. Pharmacol. 41:1997;155-177.
36. Wyllie A.H., Kerr J.R.F., Curie A.R. The significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
37. Usherwood N.R., Blagbrough I.S. Electrophysiology of polyamine amides. Carter C. The Neuropharmacology of Polyamines. 1994;185-204 Academic Press, London.
38. Quash G., Keolouanghot T., Gazzolo L., Ripoll H., Saez S. Diamine oxidase and polyamine oxidase activities in normal and transformed cells. Biochem. J. 177:1979;275-282.